BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20950648)

  • 1. Stem cell therapy for cardiovascular regeneration: the beginning or the end of all hearts' hopes.
    Madeddu P
    Pharmacol Ther; 2011 Jan; 129(1):1-2. PubMed ID: 20950648
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell therapy for cardiovascular disorders: coming of age?
    Malchesky PS
    Artif Organs; 2006 Apr; 30(4):211-2. PubMed ID: 16643379
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemplating the bright future of stem cell therapy for cardiovascular disease.
    Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells.
    Akar AR; Durdu S; Corapcioglu T; Ozyurda U
    Artif Organs; 2006 Apr; 30(4):213-32. PubMed ID: 16643380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic value of investing in regenerative medicine.
    Hussain A; Rivers PA
    J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research.
    Fuster V; Sanz J
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S1-8. PubMed ID: 17230204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cell-based therapy for structural heart disease.
    Mazhari R; Hare JM
    Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.
    Capi O; Gepstein L
    J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other approaches to fighting cardiovascular disease: stem cells and engineered tissue.
    Mason C
    Med Device Technol; 2006; 17(1):26-7. PubMed ID: 16483108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy.
    Alaiti MA; Ishikawa M; Costa MA
    Transl Res; 2010 Sep; 156(3):112-29. PubMed ID: 20801408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced stem cell activation and its implication for cardiovascular and skeletal muscle regeneration.
    Wahl P; Brixius K; Bloch W
    Minim Invasive Ther Allied Technol; 2008; 17(2):91-9. PubMed ID: 18465444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell transplant and regenerative therapy with stem cells].
    Prósper F; Gavira JJ; Herreros J; Rábago G; Luquin R; Moreno J; Robles JE; Redondo P
    An Sist Sanit Navar; 2006; 29 Suppl 2():219-34. PubMed ID: 16998528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.
    Oettgen P; Boyle AJ; Schulman SP; Hare JM
    Circulation; 2006 Jul; 114(4):353-8. PubMed ID: 16864740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cell-based regenerative therapy in cardiology: the future at present].
    Iglesias JF; Tapponnier M; Hullin R; Eeckhout E; Vogt P; Mathur A; Locca D
    Rev Med Suisse; 2012 Dec; 8(365):2364-9. PubMed ID: 23330236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell sources for cardiovascular tissue regeneration and engineering.
    Ugurlucan M; Yerebakan C; Furlani D; Ma N; Steinhoff G
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):63-73. PubMed ID: 19241306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's].
    Nadal-Ginard B; Torella D; Ellison G
    Rev Esp Cardiol; 2006 Nov; 59(11):1175-89. PubMed ID: 17144992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells.
    Tongers J; Losordo DW
    J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quest for the cardiovascular holy grail: mammalian myocardial regeneration.
    Vela D; Buja LM
    Cardiovasc Pathol; 2008; 17(1):1-5. PubMed ID: 18160054
    [No Abstract]   [Full Text] [Related]  

  • 20. Stem cells and the heart: ethics, organization and funding.
    Martin JF
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S136-7. PubMed ID: 16501621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.